Saar Gill, MBBS, PhD, FRACP Associate Professor, Medicine Biography Dr. Saar Gill is an associate professor of medicine in the division of hematology-oncology at the University of Pennsylvania. Dr. Gill trained in clinical hematology in his native Australia, followed by a post-doctoral fellowship at Stanford University. Since 2011, he has been working on developing genetically engineered immune cells for the treatment of cancer. Dr. Gill is a physician-scientist who places a strong emphasis on translational research, and concepts developed in his laboratory have already led to several clinical trials for the treatment of hematologic malignancies. Dr. Gill co-founded Carisma Therapeutics with his first graduate student, Michael Klichinsky, and recently co-founded Interius Biotherapeutics. He is a member of the American Society of Hematology Scientific Sub-Committee on Myeloid Neoplasia, elected to the American Society of Clinical Investigation, a past chair of the Cancer and Gene Therapy committee of the American Society of Gene & Cell Therapy, and a co-chair of the American Society of Transplantation and Cell Therapy’s Women, Under-represented Minorities and LGBTQ Special Interest Group. Education & Training 2008: Peter MacCallum Cancer Centre, Australia 2011: Stanford University, postdoctoral fellowship, cellular therapy University of Melbourne, Australia, MD and PhD, immunology St. Vincent’s Hospital, Australia Royal Melbourne Hospital, Australia Awards & Honors 2019: Emerging Leader Award, The Mark Foundation